- TheStreet.com•4 days ago
Sarepta Therapeutics (SRPT) met analysts' 2016 second quarter earnings expectations, recording a net loss for the quarter.
Sarepta Therapeutics, Inc.NasdaqGS
After hours: 23.890.00 (0.00%) as of 7:49 PM EDT
|Bid||23.66 x 1000|
|Ask||23.90 x 500|
|52wk Range||8.00 - 41.97|
|Day's Range||22.61 - 24.48|
|Avg Vol (3m)||6,765,182|
As of 4:00 PM EDT. Market closed.